Western Standard LLC’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $32.1M | Hold |
|
|||||
|
2023
Q4 | $29.1M | Buy |
|
|||||
|
2023
Q3 | $23.4M | Buy |
|
|||||
|
2023
Q2 | $20.6M | Hold |
|
|||||
|
2023
Q1 | $20.6M | Buy |
|
|||||
|
2022
Q4 | $17.5M | Buy |
|
|||||
|
2022
Q3 | $4.4M | Sell |
|
|||||
|
2022
Q2 | $7.55M | Buy |
|
|||||
|
2022
Q1 | $6.8M | Hold |
|
|||||
|
2021
Q4 | $4.58M | Sell |
|
|||||
|
2021
Q3 | $6.13M | Hold |
|
|||||
|
2021
Q2 | $8.11M | Buy |
|
|||||
|
2021
Q1 | $6.35M | Hold |
|
|||||
|
2020
Q4 | $6.97M | Sell |
|
|||||
|
2020
Q3 | $4.25M | Buy |
|
|||||
|
2020
Q2 | $2.9M | Buy |
|
|||||
|
2020
Q1 | $1.81M | Hold |
|
|||||
|
2019
Q4 | $2.65M | Hold |
|
|||||
|
2019
Q3 | $3.79M | Buy |
|
|||||
|
2019
Q2 | $3.78M | Buy |
|
|||||
|
2019
Q1 | $2.96M | Buy |
|
|||||
|
2018
Q4 | $580K | Buy |
|